The expression of COX-2 increased 5.9-fold in the AD group as compared with the CON group; this enhanced secretion was repressed by treatment with AD+CA-80 and AD+CA-200 (2.9-, and 1.7-fold respectively). This evidence concerns the gene PTGS2 and Alzheimer disease.